Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: AIDS. 2021 Jul 1;35(8):1191–1199. doi: 10.1097/QAD.0000000000002857

Figure 1.

Figure 1.

Median antepartum and postpartum plasma darunavir (a) and cobicistat (b) concentration versus time profiles at steady state following once-daily dosing of 800/150 mg darunavir/cobicistat. The shaded area displays the 10th to 90th percentile concentrations of darunavir in non-pregnant adults.